Definition
decrease in the concentration in the blood of total non enzymatic glycated proteins in the blood
Synonyms
reduced circulating GSP level,
decreased circulating GSP level,
decreased circulating glycated serum protein level,
reduced circulating fructosamine level,
reduced circulating glycated serum protein level
0%
of tested genes
0
significant genes
0
tested genes
IMPC Gene variants with decreased circulating fructosamine level
Total number of significant genotype-phenotype associations: 97
| Gene / Allele | Zygosity | Sex | Life Stage | Phenotype | Parameter | Phenotyping Center |
P Value |
|---|---|---|---|---|---|---|---|
| Ap2a2 Ap2a2tm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
0.00 | |
| Tnip1 Tnip1tm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
1.54×10-21 | |
| Pank3 Pank3tm1b(KOMP)Mbp |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
9.82×10-18 | |
| Arpc1b Arpc1btm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
1.84×10-13 | |
| Irgm1 Irgm1em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.46×10-13 | |
| Cxcr2 Cxcr2tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.08×10-12 | |
| Itch Itchtm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
2.72×10-11 | |
| Comt Comttm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
4.61×10-11 | |
| Vps13c Vps13ctm1b(EUCOMM)Hmgu |
HOM | Late adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
1.87×10-10 | |
| Snx8 Snx8tm2a(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.44×10-10 | |
| Col4a5 Col4a5tm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
3.67×10-10 | |
| Tmco2 Tmco2tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.96×10-09 | |
| Tex261 Tex261tm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
4.66×10-09 | |
| Myl12b Myl12btm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI MGP |
6.89×10-09 | |
| Plekhm2 Plekhm2tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI EuroPhenome |
1.14×10-08 | |
| Gdap2 Gdap2em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
1.32×10-08 | |
| Vgf Vgfem1(IMPC)H |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
1.53×10-08 | |
| Dcbld2 Dcbld2tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.41×10-08 | |
| Fbxo7 Fbxo7tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
6.07×10-08 | |
| Pfn1 Pfn1tm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI MGP |
7.16×10-08 | |
| 4933402N03Rik 4933402N03Riktm2a(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
1.29×10-07 | |
| Clpp Clpptm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.48×10-07 | |
| Usp54 Usp54tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
4.20×10-07 | |
| Hddc2 Hddc2em1(IMPC)H |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
4.26×10-07 | |
| Zranb2 Zranb2tm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Creatine kinase Clinical Chemistry |
WTSI EuroPhenome |
4.61×10-07 | |
| 4933434E20Rik 4933434E20Riktm1a(EUCOMM)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
4.74×10-07 | |
| Gmip Gmiptm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
5.53×10-07 | |
| Syt4 Syt4em2(IMPC)H |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
7.31×10-07 | |
| Tff1 Tff1tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
8.11×10-07 | |
| Slc7a8 Slc7a8tm2b(EUCOMM)Hmgu |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
8.40×10-07 | |
| Arhgap17 Arhgap17tm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
8.74×10-07 | |
| Prkaa2 Prkaa2tm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
9.12×10-07 | |
| Hexb Hexbtm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
1.08×10-06 | |
| Jmjd4 Jmjd4em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
1.20×10-06 | |
| Col4a2 Col4a2em1(IMPC)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
1.93×10-06 | |
| Tbc1d22a Tbc1d22atm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.16×10-06 | |
| Zmym4 Zmym4em1(IMPC)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.23×10-06 | |
| Pam Pamem1(IMPC)Hmgu |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
2.52×10-06 | |
| Man2b2 Man2b2tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.66×10-06 | |
| Micu2 Micu2tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.71×10-06 | |
| Sik3 Sik3tm1a(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.93×10-06 | |
| Ap3s2 Ap3s2tm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
3.50×10-06 | |
| Pdgfrb Pdgfrbtm1b(EUCOMM)Hmgu |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
3.52×10-06 | |
| Commd9 Commd9tm1b(KOMP)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
4.77×10-06 | |
| Map3k1 Map3k1tm1a(KOMP)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
5.16×10-06 | |
| Eps8l2 Eps8l2tm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
5.38×10-06 | |
| Cbr2 Cbr2tm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
5.76×10-06 | |
| Col4a5 Col4a5tm1b(EUCOMM)Wtsi |
HEM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
6.82×10-06 | |
| Nedd1 Nedd1em1(IMPC)H |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
7.65×10-06 | |
| Peds1 Peds1tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
7.66×10-06 | |
| Galnt18 Galnt18tm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
7.66×10-06 | |
| Slc7a2 Slc7a2tm1b(EUCOMM)Hmgu |
HOM | Late adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
8.03×10-06 | |
| Armc2 Armc2tm1b(EUCOMM)Hmgu |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
1.08×10-05 | |
| Tmem51 Tmem51tm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
1.10×10-05 | |
| Pes1 Pes1tm1b(EUCOMM)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
1.23×10-05 | |
| Fcho2 Fcho2tm1b(EUCOMM)Hmgu |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
1.31×10-05 | |
| Tmem178b Tmem178btm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
1.43×10-05 | |
| Ccdc127 Ccdc127tm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
1.46×10-05 | |
| Med23 Med23em1(IMPC)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
1.56×10-05 | |
| Actl10 Actl10tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
1.64×10-05 | |
| Dynll1 Dynll1tm1(KOMP)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
1.66×10-05 | |
| P3h2 P3h2em1(IMPC)H |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
1.95×10-05 | |
| Slc16a2 Slc16a2tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI MGP |
1.97×10-05 | |
| Nhp2 Nhp2tm1a(KOMP)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.79×10-05 | |
| Csnk1g3 Csnk1g3tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
2.86×10-05 | |
| Dbn1 Dbn1tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI MGP |
2.87×10-05 | |
| Ampd2 Ampd2tm1b(EUCOMM)Hmgu |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
3.37×10-05 | |
| Usp21 Usp21tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
3.38×10-05 | |
| Susd6 Susd6tm1b(KOMP)Wtsi |
HOM | Late adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
3.46×10-05 | |
| Wrap53 Wrap53tm1b(EUCOMM)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
3.59×10-05 | |
| Ceacam3 Ceacam3em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
3.72×10-05 | |
| Aff3 Aff3tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
3.74×10-05 | |
| Cabp1 Cabp1tm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
3.82×10-05 | |
| Slc5a7 Slc5a7tm1a(KOMP)Wtsi |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
3.88×10-05 | |
| Izumo1r Izumo1rtm2a(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
4.45×10-05 | |
| Usp15 Usp15tm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
5.32×10-05 | |
| Ccdc122 Ccdc122tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
5.44×10-05 | |
| Ppy Ppytm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
HMGU IMPC |
6.31×10-05 | |
| Slc17a7 Slc17a7em1(IMPC)H |
HET | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
MRC Harwell IMPC |
6.34×10-05 | |
| Gsk3a Gsk3atm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI MGP |
6.53×10-05 | |
| Atxn3 Atxn3tm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
6.98×10-05 | |
| Gda Gdatm1a(KOMP)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
7.15×10-05 | |
| Vil1 Vil1em1(IMPC)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
7.32×10-05 | |
| Arhgap30 Arhgap30tm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
7.72×10-05 | |
| Ifnar1 Ifnar1tm2a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
8.09×10-05 | |
| Sag Sagtm1a(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating fructosamine level | Fructosamine Clinical Chemistry |
WTSI IMPC |
9.45×10-05 |